NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 18, Issue 7, Pages 834-842
Publisher
Springer Nature
Online
2013-04-16
DOI
10.1038/mp.2013.32
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027
- (2012) D. M. Barten et al. JOURNAL OF NEUROSCIENCE
- The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
- (2012) B. Zhang et al. JOURNAL OF NEUROSCIENCE
- Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
- (2012) Peng Lei et al. NATURE MEDICINE
- The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities
- (2012) Saar Oz et al. PLoS One
- Increased throughput assays of locomotor dysfunction in Drosophila larvae
- (2011) C. Sinadinos et al. JOURNAL OF NEUROSCIENCE METHODS
- Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model
- (2011) Anat Idan-Feldman et al. NEUROBIOLOGY OF DISEASE
- Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo
- (2010) Catherine M. Cowan et al. ACTA NEUROPATHOLOGICA
- Tau Pathology and Future Therapeutics
- (2010) I. Gozes Current Alzheimer Research
- Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
- (2010) C. Ballatore et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases
- (2010) H. Sudo et al. HUMAN MOLECULAR GENETICS
- Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
- (2010) K. R. Brunden et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
- (2010) Kurt R. Brunden et al. PHARMACOLOGICAL RESEARCH
- Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons
- (2009) C. Sinadinos et al. NEUROBIOLOGY OF DISEASE
- NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
- (2009) Natalia Shiryaev et al. NEUROBIOLOGY OF DISEASE
- The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush
- (2008) T. Jehle et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease
- (2008) Y. Matsuoka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide
- (2003) Merav Bassan et al. JOURNAL OF NEUROCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now